Vanguard Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $314M | Buy |
|
|||||
|
2019
Q2 | $325M | Buy |
|
|||||
|
2019
Q1 | $343M | Buy |
|
|||||
|
2018
Q4 | $114M | Buy |
|
|||||
|
2018
Q3 | $154M | Buy |
|
|||||
|
2018
Q2 | $228M | Buy |
|
|||||
|
2018
Q1 | $176M | Buy |
|
|||||
|
2017
Q4 | $133M | Buy |
|
|||||
|
2017
Q3 | $220M | Buy |
|
|||||
|
2017
Q2 | $115M | Buy |
|
|||||
|
2017
Q1 | $97.5M | Buy |
|
|||||
|
2016
Q4 | $86.7M | Buy |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $77.3M | Buy |
|
|||||
|
2016
Q1 | $34.6M | Buy |
|
|||||
|
2015
Q4 | $49.6M | Buy |
|
|||||
|
2015
Q3 | $32.4M | Buy |
|
|||||
|
2015
Q2 | $27.7M | Buy |
|
|||||
|
2015
Q1 | $32.9M | Buy |
|